Bone Marrow Examination Panel 2 Test in UAE | 450 AED | DHA Licensed Laboratory

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Collection Protocol: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Complimentary telephonic post-test result interpretation with a DHA-licensed specialist.
Insurance: Direct Billing Verification – send your insurance card via WhatsApp to +971 54 548 8731 before booking.

Test Overview & Methodology

The Bone Marrow Examination Panel 2 is an advanced multi-parametric analysis combining cytopathology, specialized staining, and in‑situ hybridization to characterize hematopoietic disorders. This panel serves as the definitive diagnostic gateway for leukaemias, myelodysplastic syndromes, and unexplained cytopenias.

Feature	Our Panel (Panel 2)	Routine Bone Marrow Aspirate
Precision/Tech	Electrical Impedance, VCS, HPE, ISH & Special Stains (Gram, ZN, PAS, etc.)	Microscopy with Giemsa only
Sensitivity	99.9% (ISO‑validated protocol)	~85% (no molecular/ISH confirmation)
Turnaround Time	5 working days (sample accepted daily by 6 pm)	7–10 working days typical

Physician Insight & Safety Protocols

Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology | DHA Registration ID: 61713011) notes:

“Undergoing a bone marrow examination can feel overwhelming, but it is the most direct window into your blood‑forming system. We have refined sample collection to be as gentle as possible, and every result is correlated with your full clinical picture. I encourage you to discuss all pre‑test instructions with your haematologist.”

⚠️ Pre-Procedure Advisory

Do not discontinue any prescribed medication (especially anticoagulants, antiplatelets, or insulin) without explicit clearance from your treating physician. Abrupt cessation can lead to life‑threatening complications.

Exclusion Criteria & ER Red Flags

Active bleeding disorder or severe thrombocytopenia (<20×10⁹/L) without platelet cover.
Infection or open wound at the biopsy site.
Uncooperative patient or inability to lie still for the procedure.
Seek immediate emergency care if you develop persistent bleeding, excessive pain, fever >38.5°C, or purulent discharge at the biopsy site post‑procedure.

Patient FAQ & Clinical Guidance

1. What exactly is the Bone Marrow Examination Panel 2 Test?

A comprehensive panel that evaluates bone marrow aspirate and biopsy using advanced microscopy, staining, and hybridization to diagnose blood cancers and marrow failure.

2. Why would my doctor order this?

It is requested to investigate unexplained cytopenias, suspected leukaemia or lymphoma, staging of haematological malignancies, and monitoring response to therapy.

3. What preparation is required before the procedure?

You must complete Form 14 (Bone Marrow Examination Requisition), and the sample is collected under local anaesthesia with strict sterile technique; no fasting is usually needed unless specified by your doctor.

4. Where does the sample collection take place?

The procedure is performed exclusively at an accredited hospital under the supervision of a qualified specialist. Home phlebotomy is not available for this invasive test.

UAE Regulatory & Data Privacy Adherence

Our laboratory operates under DHA Facility License Number 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. We fully comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, access-controlled, and never shared without explicit consent. For any privacy concerns, contact our compliance team.

Clinical & Logistical Metadata

Test Name	Bone Marrow Examination Panel 2
Price (AED)	450 AED
Turnaround Time	5 working days
Sample Type / Matrix	Bone Marrow Aspirate (EDTA), Bone Marrow Trephine Biopsy (10% formal saline), Peripheral Blood Smears
Methodology Used	Electrical Impedance, VCS, HPE, In-Situ Hybridization (ISH), Special Stains (Gram, ZN, PAS, etc.)
ICD-10-CM Code	D46.9
LOINC Code	65983-3
DHA Facility License & Address	Facility No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE